Cellarity
Alejandra Macias-Garcia is an experienced scientist specializing in in vivo pharmacology and drug discovery. Currently serving as Associate Director of In vivo Pharmacology at Cellarity since September 2020, Alejandra previously held positions at Sanofi, where duties included designing and executing in vivo studies and conducting pharmacokinetic/pharmacodynamic studies. Prior roles include Scientist I at Bioverativ, focusing on small molecule programs, and a postdoctoral fellowship at the Massachusetts Institute of Technology, centered on iron deficiency anemia models. Alejandra earned a PhD in Molecular Biology from the University of Strasbourg and holds a Master's degree in Molecular Biology from Universidad Autónoma de Nuevo León, along with a Bachelor's degree in Chemistry Bacteriologist Parasitologist from Universidad Autónoma de Chihuahua.
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.